Tag Archive for: wellington

SciRhom management: Jens Ruhe, COO, Jan Poth, CEO, und Matthias Schneider, CSO. © SciRhom/ Paul Paulsen

German iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.

First structural description of butyrophilins. ©J Biol Chem. 2012 Sep 21; 287(39): 3278032790, Daniel Olive et al.

ImCheck Therapeutics located in Marseille, France, announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird and Andera Partners. Kurma Partners, Eurazeo, Gimv, Pfizer, Bpifrance through its Innobio 2 and Large Venture funds, Wellington Partners, Pureos Bioventures, Agent Capital and Alexandria Venture Investments are invested already. Invus and The Leukemia & Lymphoma
Society Therapy Acceleration Program also joined the round as new investors.